Randel William Woodgrift - Sep 3, 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
SENIOR VICE PRESIDENT
Signature
/s/ Randel W. Woodgrift by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Sep 3, 2021
Transactions value $
-$780,750
Form type
4
Date filed
9/8/2021, 05:28 PM
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $38.4K +1K +2.04% $38.40 50.1K Sep 3, 2021 Direct
transaction ABT Common shares without par value Sale -$129K -1K -2% $129.00 49.1K Sep 3, 2021 Direct
transaction ABT Common shares without par value Sale -$690K -5.35K -10.9% $129.00 43.7K Sep 3, 2021 Direct
holding ABT Common shares without par value 3.22K Sep 3, 2021 Profit Sharing Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -1K -42.86% $0.00 1.33K Sep 3, 2021 Common Shares 1K $38.40 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance in the Abbott Laboratories Stock Retirement Trust as of September 7, 2021.
F2 Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).